☆Decheng Capital LLC
Quality Q
0.924
AUM ($M)
732
Positions
14
Turnover
0.06
Top-10 wt
98%
Herfindahl
0.427
History (qtrs)
6
Excess Return
—
AI Eval Run AI Eval
Holdings · 15 positions · portfolio value $732M
| Ticker | Name | Activity | Security Type | Weight | Δ Weight | Value ($M) | Shares | Δ Shares | Qtrs Held | Excess Return |
|---|---|---|---|---|---|---|---|---|---|---|
| ☆CGON funds › | CG ONCOLOGY INC | HOLD | — | 61.9% | -3.3% | 452.7 | 6,371,669 | +0 | 5 | — |
| ☆NUVB funds › | Nuvation Bio Inc. | HOLD | — | 20.1% | +3.3% | 147.4 | 25,954,439 | +0 | 5 | — |
| ☆AARD funds › | AARDVARK THERAPEUTICS INC | HOLD | — | 3.1% | +0.9% | 22.6 | 3,917,299 | +0 | 5 | — |
| ☆ACRS funds › | Aclaris Therapeutics, Inc. | HOLD | — | 2.9% | +0.6% | 21.4 | 4,041,736 | +0 | 5 | — |
| ☆UPB funds › | Upstream Bio Inc. | HOLD | — | 2.6% | -1.1% | 18.9 | 2,724,868 | +0 | 5 | — |
| ☆RCUS funds › | Arcus Biosciences, Inc | TRIM | — | 2.0% | +0.4% | 14.3 | 464,779 | -13,040 | 5 | — |
| ☆EQ funds › | Equillium Inc. | HOLD | — | 1.9% | +0.6% | 14.2 | 4,447,308 | +0 | 5 | — |
| ☆RVMD funds › | REVOLUTION MEDICINES INC(NSM) | TRIM | — | 1.3% | -0.0% | 9.9 | 52,667 | -40,833 | 5 | — |
| ☆CUSIP:55083R104 funds › | Lyell Immunopharma, Inc. | HOLD | — | 1.3% | -0.8% | 9.7 | 692,050 | +0 | 5 | — |
| ☆BYSI funds › | BeyondSpring Inc. | HOLD | — | 0.9% | -0.0% | 6.7 | 3,800,702 | +0 | 5 | — |
| ☆ZNTL funds › | Zentalis Pharmaceuticals Inc. | HOLD | — | 0.9% | +0.4% | 6.4 | 1,323,327 | +0 | 5 | — |
| ☆NAMS funds › | NEWAMSTERDAM PHARMA CO NV | TRIM | — | 0.8% | -0.8% | 6.0 | 176,887 | -148,170 | 5 | — |
| ☆PYXS funds › | Pyxis Oncology, Inc (formerly Apexigen) | HOLD | — | 0.1% | +0.1% | 1.0 | 326,810 | +0 | 5 | — |
| ☆TNGX funds › | TANGO THERAPEUTICS INC | NEW | — | 0.1% | +0.1% | 0.6 | 20,000 | +20,000 | 1 | — |
| ☆KRYS funds › | KRYSTAL BIOTECH INC | EXIT | — | 0.0% | -0.3% | 0.0 | 0 | -7,300 | 0 | — |
Point-in-time history
| Period | AUM ($M) | Positions | Turnover | Top-10 wt | Herfindahl | Quality Q | Skill | Universe |
|---|---|---|---|---|---|---|---|---|
| 2026Q2 | 732 | 14 | 0.06 | 98% | 0.427 | 0.923 | — | in |
| 2026Q1 | 661 | 14 | 0.31 | 98% | 0.457 | 0.602 | — | in |
| 2025Q4 | 743 | 19 | 0.18 | 97% | 0.245 | 0.795 | — | in |
| 2025Q3 | 573 | 23 | 0.11 | 94% | 0.252 | 0.830 | — | in |
| 2025Q2 | 396 | 25 | 0.10 | 92% | 0.222 | 0.825 | — | entered |
| 2025Q1 | 356 | 27 | 0.00 | 86% | 0.225 | 0.000 | — | out |
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short.
JSON: /api/signals ·
/api/funds ·
/api/status